At CD Formulation, we are dedicated to providing outstanding sterility testing for nucleic acid drugs. Utilizing cutting-edge technologies and equipment, our services detect even the smallest contaminants in complex samples, ensuring purity is upheld during every phase of drug development.
Sterility testing for nucleic acid drugs is a crucial step in ensuring safety and quality. Although nucleic acid drugs do not inherently support microbial growth, any potential microbial contamination poses a risk to patient safety. Therefore, we conduct rigorous sterility testing by detecting microbial growth in specific media to ensure product purity and efficacy. Additionally, we combine technology with good manufacturing practices to achieve high-standard environmental control. These stringent measures adhere to international standards, ensuring our nucleic acid drugs are safe and reliable when put to use.
Fig.1 The advantages of sterility testing for nucleic acid drugs. (CD Formulation)
By directly inoculating samples into an efficient culture medium, potential microorganisms can rapidly grow and be effectively detected. Our professional technical team rigorously supervises the entire testing process to ensure the accuracy and verifiability of each result. If any turbidity arise during testing, we promptly conduct an in-depth analysis to confirm that the occurrence is not linked to inherent sample properties. Our service aims to provide unparalleled sterility verification for your product, ensuring it meets the strictest quality standards at both development and production stages.
Through membrane filtration, we can precisely capture and concentrate microorganisms in samples, allowing them to grow to an observable state on specific media. For samples that may contain inhibitory components, our carefully designed rinsing process effectively removes interfering factors, ensuring that microorganisms retained on the filter can fully grow and be accurately detected. Our service not only enhances the precision of the test but also strengthens the safety and reliability of the product, providing robust sterility assurance for your research and production activities.
We conduct specialized antibacterial and antifungal tests alongside sterility testing to ensure that the sample does not inhibit microbial growth. This B/F testing validates the accuracy of sterility results, ensuring no antimicrobial characteristics influence microbial testing in the sample.
Utilizing vaporized hydrogen peroxide (VHP) purification technology, we perform penetration testing in isolated environments. This test effectively evaluates the permeability of VHP to sample containers, ensuring it does not affect the accuracy of analytical results and guaranteeing the reliability of nucleic acid drug testing.
For nucleic acid products, our rapid sterility testing surpasses traditional culture methods, offering innovative services. Unlike the lengthy pharmacopeial sterility tests, rapid sterility testing can be completed in a shorter time frame, enhancing efficiency and ensuring the microbiological safety of products throughout the production cycle.
Fig.2 Flow chart of sterility testing for nucleic acid drugs. (CD Formulation)
Samples are collected and processed within a sterile environment using strictly calibrated instruments to maintain conditions as close as possible to those during production.
An initial sterility test is conducted on nucleic acid samples to ensure they are free from common microbial contaminants.
Samples undergo a detailed microbial examination using media and microscopic inspection methods, and all observations are recorded to detect even low concentrations of contaminants.
Upon confirmation that analysis results are safe and compliant, a detailed quality report is generated, including the testing process, results, and any professional evaluations of anomalies.
Platforms | Descriptions |
---|---|
HPLC Platform | Our platform is employed for the precise separation of nucleic acid drug samples, with high sensitivity to detect potential trace contaminants for high-precision sterility analysis. |
qPCR Platform | Leveraging high specificity and sensitivity, this platform is used for the rapid identification of DNA or RNA microbial contamination in samples, effectively ensuring the sterility of nucleic acid drugs. |
Technology: Formulation safety analysis utilizing sterility testing
Journal: American Journal of Pharmaceutical Education
IF: 3.8
Published: 2016
Results:
This 1-credit course, Compounded Sterile Preparations Laboratory, uses a constructivist approach to teach aseptic techniques essential for health systems. By integrating cross-curricular concepts, the course fosters critical thinking for sterile compounding. Student skills were assessed through structured rubrics, achieving an average grade of 83.2%. Nearly all students passed practical media fill (98%) and gloved fingertip tests (86%) on their first try, with all succeeding by the second attempt. This educational framework effectively equips students with the required proficiency in aseptic and hygiene practices.
Fig.3 Sterility testing pass rates in the compounded sterile preparations course. (Nemec E C, et al., 2016)
For any inquiries or specific requirements about our nucleic acid drug sterility testing services, please contact us. Our experienced professionals are on standby to offer expert guidance and support, aiding you in reaching your research and development targets.
References